Castleview Partners’s Stryker SYK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.28M Buy
11,899
+3,567
+43% +$1.12M 1.44% 14
2026
Q2
$2.62M Buy
+8,332
New +$2.63M 1.15% 16
2024
Q3
– Sell
-218
Closed -$74.2K – 879
2024
Q2
$74.2K Buy
218
+132
+153% +$44.7K 0.04% 270
2024
Q1
$30.8K Buy
86
+14
+19% +$4.71K 0.02% 410
2023
Q4
$21.6K Buy
+72
New +$20.2K 0.02% 428

Other funds holding SYK

Castleview Partners's SYK Position: Q3 2026 in Review

Castleview Partners increased its Stryker (SYK) stake by 43% in Q3 2026, buying an estimated $1.12M and bringing the position to 11,899 shares worth $3.28M. The position accounts for 1.44% of the portfolio, ranked #14.

Castleview Partners first reported a position in SYK in Q4 2023 and has held it in 5 quarters since. 1,260 funds tracked by Wall St. Rank hold SYK as of Q3 2026.

  • Castleview Partners held 11,899 shares of Stryker worth $3.28M as of Q3 2026.
  • Castleview Partners bought 3,567 Stryker shares in Q3 2026, an estimated $1.12M.
  • Stryker made up 1.44% of Castleview Partners's portfolio in Q3 2026, its #14 holding.
  • Castleview Partners first reported a position in Stryker in Q4 2023 and has held it in 5 quarters since.
  • 1,260 funds tracked by Wall St. Rank held Stryker as of Q3 2026.

Based on Castleview Partners's 13F filing for Q3 2026, filed 9 Oct 2026.